These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30236398)

  • 1. Development of Heart Failure From Transient Atrial Fibrillation Attacks in Responders to Cardiac Resynchronization Therapy.
    Nakajima I; Noda T; Kanzaski H; Kamakura T; Wada M; Ishibashi K; Inoue Y; Miyamoto K; Okamura H; Nagase S; Aiba T; Kamakura S; Noguchi T; Yasuda S; Akashi YJ; Kusano KF
    JACC Clin Electrophysiol; 2018 Sep; 4(9):1227-1234. PubMed ID: 30236398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy.
    Boriani G; Gasparini M; Landolina M; Lunati M; Proclemer A; Lonardi G; Iacopino S; Rahue W; Biffi M; DiStefano P; Grammatico A; Santini M;
    Eur J Heart Fail; 2011 Aug; 13(8):868-76. PubMed ID: 21558331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation incidence and impact of biventricular pacing on long-term outcome in patients with heart failure treated with cardiac resynchronization therapy.
    Jacobsson J; Reitan C; Carlson J; Borgquist R; Platonov PG
    BMC Cardiovasc Disord; 2019 Aug; 19(1):195. PubMed ID: 31409276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidemic of inadequate biventricular pacing in patients with persistent or permanent atrial fibrillation and its association with mortality.
    Ousdigian KT; Borek PP; Koehler JL; Heywood JT; Ziegler PD; Wilkoff BL
    Circ Arrhythm Electrophysiol; 2014 Jun; 7(3):370-6. PubMed ID: 24838004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does permanent atrial fibrillation modify response to cardiac resynchronization therapy in heart failure patients?
    Abreu A; Oliveira M; Silva Cunha P; Santa Clara H; Portugal G; Gonçalves Rodrigues I; Santos V; Morais L; Selas M; Soares R; Branco L; Ferreira R; Mota Carmo M;
    Rev Port Cardiol; 2017 Oct; 36(10):687-694. PubMed ID: 29031455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy in patients with atrial fibrillation: the CERTIFY study (Cardiac Resynchronization Therapy in Atrial Fibrillation Patients Multinational Registry).
    Gasparini M; Leclercq C; Lunati M; Landolina M; Auricchio A; Santini M; Boriani G; Lamp B; Proclemer A; Curnis A; Klersy C; Leyva F
    JACC Heart Fail; 2013 Dec; 1(6):500-7. PubMed ID: 24622002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    Hwang JK; Gwag HB; Park KM; On YK; Kim JS; Park SJ
    PLoS One; 2019; 14(1):e0210603. PubMed ID: 30633768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of cardiac resynchronization therapy in patients with intermittent atrial fibrillation or atrial flutter in the COMPANION trial.
    Kalscheur MM; Saxon LA; Lee BK; Steinberg JS; Mei C; Buhr KA; DeMets DL; Bristow MR; Singh SN
    Heart Rhythm; 2017 Jun; 14(6):858-865. PubMed ID: 28323173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac resynchronization therapy defibrillators in patients with permanent atrial fibrillation.
    Rapacciuolo A; Iacopino S; D'Onofrio A; Curnis A; Pisanò EC; Biffi M; Della Bella P; Dello Russo A; Caravati F; Zanotto G; Calvi V; Rovaris G; Senatore G; Nicolis D; Santamaria M; Giammaria M; Maglia G; Duca A; Ammirati G; Romano SA; Piacenti M; Celentano E; Bisignani G; Vaccaro P; Miracapillo G; Bertini M; Nigro G; Giacopelli D; Gargaro A; Bisceglia C
    ESC Heart Fail; 2021 Dec; 8(6):5204-5212. PubMed ID: 34514741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between device-detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator.
    Arai S; Kawamura M; Gokan T; Yoshikawa K; Ogawa K; Ochi A; Munetsugu Y; Ito H; Shinke T
    Clin Cardiol; 2020 Dec; 43(12):1517-1523. PubMed ID: 32989791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cardiac resynchronization on the incidence of atrial fibrillation in patients with severe heart failure.
    Hoppe UC; Casares JM; Eiskjaer H; Hagemann A; Cleland JG; Freemantle N; Erdmann E
    Circulation; 2006 Jul; 114(1):18-25. PubMed ID: 16801461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of survival for cardiac resynchronization therapy in atrial fibrillation patients with or without atrio-ventricular junction ablation and patients in sinus rhythm: a systematic review and network meta-analysis.
    Xue Y; Wang J; Wang J; Thapa S; Huang K; Peng Y; Qian L; Li J; Ji K
    Heart Fail Rev; 2019 May; 24(3):335-342. PubMed ID: 30610455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation burden and subsequent heart failure events in patients with cardiac resynchronization therapy devices.
    Tanawuttiwat T; Lande J; Smeets P; Gerritse B; Nazarian S; Guallar E; Cheng A
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1519-1526. PubMed ID: 32162753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atrial fibrillation on improvement of functional mitral regurgitation in cardiac resynchronization therapy.
    van der Bijl P; Vo NM; Leung M; Ajmone Marsan N; Delgado V; Stone GW; Bax JJ
    Heart Rhythm; 2018 Dec; 15(12):1816-1822. PubMed ID: 30017815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study.
    Eisen A; Nevzorov R; Goldenberg G; Kuznitz H; Porter A; Golovtziner G; Strasberg B; Haim M
    Pacing Clin Electrophysiol; 2013 Jul; 36(7):872-7. PubMed ID: 23594360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of rhythm outcomes after cardiac resynchronization therapy in atrial fibrillation patients: When should we use an atrial lead?
    Nedios S; Doering M; Darma A; Lucas J; Dinov B; Arya A; Dagres N; Hindricks G; Bollmann A; Richter S; Bode K
    Clin Cardiol; 2021 Feb; 44(2):210-217. PubMed ID: 33295029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case selection for cardiac resynchronization in atrial fibrillation.
    Cleland JG; Keshavarzi F; Pellicori P; Dicken B
    Heart Fail Clin; 2013 Oct; 9(4):461-74, ix. PubMed ID: 24054479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
    Röger S; Schneider R; Rudic B; Liebe V; Stach K; Schimpf R; Borggrefe M; Kuschyk J
    Europace; 2014 Aug; 16(8):1205-9. PubMed ID: 24706089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.